End of this quarter they should be @ US$ 10.2 million in net cash and receivables @ A$ 0.45 per share market cap is US$37.9 million ..... so 25% of the current market cap is net cash.
If they can recover some lost contract sales momentum to get and keep annual revenue at US$ 30 million you will be looking at free cashflow of between US$ 5 and US$ 6 million per year. Stripping our net cash and using the 5 million figure that is 5.5 x market cap (after deducting net cash).
It is all about the sales, if they can get back to showing some contracted sales growth then stock is very well positioned for a very significant rebound. All comes down to signing new contracts, backdrop is supportive in the longer term, can management translate that supportive backdrop ?
- Forums
- ASX - By Stock
- Ann: Business Update and Appendix 4C - amended
CGS
cogstate ltd
Add to My Watchlist
0.61%
!
$1.66

End of this quarter they should be @ US$ 10.2 million in...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.66 |
Change
0.010(0.61%) |
Mkt cap ! $280.4M |
Open | High | Low | Value | Volume |
$1.65 | $1.68 | $1.62 | $34.96K | 21.09K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 621 | $1.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 2298 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 621 | 1.610 |
7 | 7699 | 1.600 |
1 | 3785 | 1.585 |
3 | 10722 | 1.575 |
1 | 829 | 1.570 |
Price($) | Vol. | No. |
---|---|---|
1.680 | 2298 | 1 |
1.710 | 10000 | 1 |
1.740 | 1000 | 1 |
1.750 | 1758 | 1 |
1.790 | 1789 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
CGS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online